Screener
ImmunityBio, Inc. IBRX Reportable Segment — Interest Expense, Other
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by ImmunityBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InterestExpenseOther.
The source filing: ImmunityBio, Inc.’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 7:37 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001326110-26-000059
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Change in fair value of warrant liabilities | (295,413) | (448) |
| Change in fair value of related-party convertible note | (236,625) | (42,582) |
| Interest expense – related party | (14,559) | (15,313) |
| Interest expense related to revenue interest liability | (13,871) | (13,534) |
| Change in fair value of derivative liabilities | 1,108 | 5,578 |
| Interest expense | (34) | (18) |
| Other expense, net | (5,917) | (41) |
| Total other expense, net | (562,997) | (65,471) |
ITEM 1. FINANCIAL STATEMENTS.
FAQ
- What is ImmunityBio, Inc.'s reportable segment — interest expense, other?
- ImmunityBio, Inc. (IBRX) reported reportable segment — interest expense, other of $13.87M in Q1 2026.
- How has ImmunityBio, Inc.'s reportable segment — interest expense, other changed year-over-year?
- ImmunityBio, Inc.'s reportable segment — interest expense, other increased by 2.5% year-over-year, from $13.53M to $13.87M.
- What is the long-term trend for ImmunityBio, Inc.'s reportable segment — interest expense, other?
- Over 2 years (2023 to 2025), ImmunityBio, Inc.'s reportable segment — interest expense, other has grown at a 867.9% compound annual growth rate (CAGR), from $264K to $24.73M.
- What does reportable segment — interest expense, other mean?
- Includes all interest-related costs not specifically categorized under related-party debt, such as interest on third-party loans, credit facilities, or lease liabilities. It represents the broader cost of servicing the company's debt obligations.
Ask your AI about ImmunityBio, Inc.'s reportable segment — interest expense, other.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude